Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation-Reference-Cited by-同舟云学术

Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation

Published:2014-10-04 Issue:3 Volume:168 Page:429-442
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Maxwell Perry¹²,Melendez-Rodríguez Florinda³,Matchett Kyle B.²,Aragones Julian³,Ben-Califa Nathalie⁴,Jaekel Heidelinde⁵,Hengst Ludger⁵⁶,Lindner Herbert⁶,Bernardini Andre⁷,Brockmeier Ulf⁷,Fandrey Joachim⁷,Grunert Fritz⁸,Oster Howard S.⁹,Mittelman Moshe⁹,El-Tanani Mohamed²,Thiersch Markus¹⁰,Schneider Gasser Edith M.¹⁰,Gassmann Max¹⁰¹¹,Dangoor David¹²,Cuthbert Robert J.¹³,Irvine Alexandra²,Jordan Anne²,Lappin Terence²,Thompson John⁸,Neumann Drorit⁴

Affiliation:

1. Northern Ireland Molecular Pathology Laboratory; Belfast Health & Social Care Trust; Queen's University Belfast; Belfast UK

2. Centre for Cancer Research and Cell Biology; Queen's University Belfast; Belfast UK

3. Hospital Universitario Santa Cristina; Autonomous University of Madrid; Madrid Spain

4. Department of Cell and Developmental Biology; Sackler Faculty of Medicine; Tel Aviv University; Tel-Aviv Israel

5. Division of Medical Biochemistry; Biocentre; Innsbruck Medical University; Innsbruck Austria

6. Division of Clinical Biochemistry; Biocentre; Innsbruck Medical University; Innsbruck Austria

7. Insitute of Physiology; University Duisburg Essen; Essen Germany

8. Aldevron Freiburg GmbH; Freiburg Germany

9. Department of Internal Medicine A; Tel Aviv Sourasky Medical Centre; Tel Aviv University; Tel Aviv Israel

10. Institute of Veterinary Physiology; Zurich Centre for Integrative Human Physiology (ZIHP); University of Zurich; Zurich Switzerland

11. Universidad Peruana Cayetano Heredia (UPCH); Lima Peru

12. OSM-DAN Ltd; Rehovot Israel

13. Belfast Health & Social Care Trust; Belfast UK

Funder

This study was supported by the FP7-Health European commission EpoCan grant

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13133/fullpdf

Reference34 articles.

1. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors;Abramsson;The Journal of Clinical Investigation,2003

2. Erythropoietin receptor mRNA expression in human endothelial cells;Anagnostou;Proceedings of the National Academy of Sciences of the United States of America,1994

3. Expression of erythropoietin receptor splice variants in human cancer;Arcasoy;Biochemical and Biophysical Research Communications,2003

4. Erythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificity;Brown;Stem Cells,2007

5. Erythropoietin: multiple targets, actions, and modifying influences for biological and clinical consideration;Broxmeyer;Journal of Experimental Medicine,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EpoR Activation Stimulates Erythroid Precursor Proliferation by Inducing Phosphorylation of Tyrosine-88 of the CDK-Inhibitor p27Kip1;Cells;2023-06-23

2. Erythropoietin receptor regulates tumor mitochondrial biogenesis through iNOS and pAKT;Frontiers in Oncology;2022-08-16

3. Anemia of Chronic Diseases: Wider Diagnostics—Better Treatment?;Nutrients;2020-06-16

4. Effect of fetal bovine serum on erythropoietin receptor expression and viability of breast cancer cells;Saudi Journal of Biological Sciences;2020-02

5. Identification of protein-protein interactions using a magnetic modulation biosensing system;Sensors and Actuators B: Chemical;2020-01